Protection against blood-brain barrier disruption in focal cerebral ischemia by the type IV phosphodiesterase inhibitor BBB022: A quantitative study

Brain Research

Volumn 787, Issue 2, 1998, Pages 277-285

  Belayev, Ludmila ^a   Busto, Raul ^a   Ikeda, Masuhiro ^b   Rubin, Lee L ^b   Kajiwara, Akiharu ^c   Morgan, Louise ^b   Ginsberg, Myron D ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c EISAI CO LTD   (Japan)

Author keywords

BBB; BBB022; Evans blue; Middle cerebral artery occlusion; Rat

Indexed keywords

BBB 022; EVANS BLUE; HALOTHANE; PHOSPHODIESTERASE IV INHIBITOR; POLYLYSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ISCHEMIA; CONTROLLED STUDY; EXTRAVASATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032559861     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01499-6     Document Type: Article

References (36)

1. Barnard J.W., Seibert A.F., Prasad V.R., Smart D.A., Strada S.J., Taylor A.E., Thompson W.J. Reversal of pulmonary capillary ischemia-reperfusion injury by rolipram, a cAMP phosphodiesterase inhibitor. J. Appl. Physiol. 77:1994;774-781.
2. Beavo J.A., Reifsnyder D.H. Primary sequence of cyclic nucleotid phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol. Sci. 11:1990;150-155.
3. Bederson J.B., Pitts L.H., Tsuji M., Nishimura M.C., Davis R.L., Bartkowski H. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 17:1986;472-476.
4. Belayev L., Alonso O.F., Busto R., Zhao W., Ginsberg M.D. Middle cerebral artery occlusion in the rat by intraluminal suture: neurological and pathological evaluation of an improved model. Stroke. 27:1996;1616-1623.
5. Belayev L., Busto R., Zhao W., Ginsberg M.D. HU-211, a novel non-competitive NMDA antagonist, improves neurological deficit and reduces infarct volume after reversible focal cerebral ischemia in the rat. Stroke. 26:1995;2313-2320.
6. Belayev L., Busto R., Zhao W., Ginsberg M.D. Quantitative evaluation of blood-brain barrier permeability following middle cerebral artery occlusion in rats. Brain Res. 739:1996;88-96.
7. Bhakoo K.K., Crockard H.A., Lascelles P.C., Avery S.F. Prostaglandin synthesis and oedema formation during reperfusion following experimental brain ischemia in the gerbil. Stroke. 15:1984;891-895.
8. Bradbury M.W. The blood-brain barrier. Transport across the cerebral endothelium. Circ. Res. 57:1985;213-222.
9. Cervos-Navarro J., Artigas J., Mrsulja B.J. Morphofunctional aspects of the normal and pathological blood-brain barrier. Acta Neuropathol. VIII:1983;1-19.
10. De Ryck M., Reempts J.V., Borgers M., Wauquier A., Janssen P.A.J. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarct in rats. Stroke. 20:1989;1383-1390.
11. Durieu-Trautmann O., Federici C., Creminon C., Foignant-Chaverot N., Roux F., Claire M., Strosberg A.D., Couraud P.O. Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J. Cell Physiol. 155:1993;104-111.
12. Giembycz M.A. Could isozyme-selective phosphodiesterase inhibitors render bronchodilator therapy redundant in the treatment of bronchial asthma? Biochem. Pharmacol. 43:1992;2041-2051.
13. 125I-albumin. Stroke. 16:1985;101-109.
14. Hirase T., Staddon J.M., Saitou M., Ando-Akatsuka Y., Itoh M., Furuse M., Fujimoto K., Tsukita S., Rubin L.L. Occludin as a possible determinant of tight junction permeability in endothelial cells. J. Cell Sci. 110:1997;1603-1613.
15. Hjelle J.T., Baird-Lambert J., Cardinale G., Spector S., Udenfriend S. Isolated microvessels: The blood-brain barrier in vitro. Proc. Natl. Acad. Sci. U.S.A. 75:1978;4544-4548.
16. B.B. Johansson, The physiology of the blood-brain barrier, in: J.C. Porter, D. Jezova (Eds.), Circulating Regulatory Factors and Neuroendocrine Function, Plenum, New York, 1990, pp. 25-39.
17. Kato H., Araki T., Itoyama Y., Kogure K. Rolipram, a cyclic AMP-selective phosphodiesterase inhibitor, reduces neuronal damage following cerebral ischemia in the gerbil. Eur. J. Pharmacol. 272:1995;107-110.
18. Markgraf C.G., Green E.J., Watson B., McCabe P.M., Schneiderman N., Dietrich W.D., Ginsberg M.D. Recovery of sensorimotor function after distal middle cerebral artery photothrombotic occlusion in rats. Stroke. 25:1994;153-159.
19. Nicholson C.D., Challiss R.A.J., Shahid M. Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes. TiPS. 12:1991;19-27.
20. Ogawa S., Koga S., Kuwabara K., Brett J., Morrow B., Morris S., Bilezikian J., Silverstein S., Stern D. Hypoxia-induced increased permeability of endothelial monolayers occurs through lowering of cellular cyclic AMP levels. Am. J. Physiol. 262:1992;C546-C554.
21. Rawson R.A. The binding of T-1824 and structurally related diazo dyes by plasma proteins. Am. J. Physiol. 138:1943;708-717.
22. Reese T.S., Karnovsky M.J. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J. Cell Biol. 34:1967;207-217.
23. Risau W., Wolburg H. Development of the blood-brain barrier. Trends Neurosci. 13:1990;174-178.
24. Rubin L.L., Hall D.E., Porter S., Barbu K., Cannon C., Horner H.C., Janatpour M., Liaw C.W., Manning K., Morales J., Tuanner L.I., Tomaselli K.J., Bard F. A cell culture model of the blood-brain barrier. J. Cell Biol. 115:1991;1725-1735.
25. Sadoshima S., Fujishima M., Ogata J., Ibayashi S., Shiokawa O., Omae T. Distribution of blood-brain barrier following bilateral carotid artery occlusion in spontaneously hypertensive rats, A quantitative study. Stroke. 14:1983;876-882.
26. Sakaki T., Tsunoda S., Morimoto T. The influence of the calcium antagonist nimodipine and induced hypertension on the behavior of the cerebral pial arteries, the blood-brain barrier, cerebral edema, and cerebral infarction in cats with one-hour occlusion of the middle cerebral artery. Neurosurgery. 28:1991;267-272.
27. Staddon J.M., Herrenknecht K., Smales C., Rubin L.L. Evidence that tyrosine phosphorylation may increase tight junction permeability. J. Cell Sci. 106:1995;609-619.
28. Staddon J.M., Rubin L.L. Cell adhesion, cell junctions and the blood-brain barrier. Curr. Opin. Neurobiol. 6:1996;622-627.
29. Steinwall O., Klatzo I. Selective vulnerability of the blood-brain barrier in chemically induced lesions. J. Neuropathol. Exp. Neurol. 25:1966;542-559.
30. Stelzner T., Weil J., O'Brien R. Role of cyclic adenosine monophosphate in the induction of endothelial barrier properties. J. Cell. Physiol. 139:1989;157-166.
31. Sztriha L., Joo F., Szerdahelyi P., Eck E., Koltai M. Effects of dexamethasone on brain edema induced by kainic acid seizures. Neuroscience. 17:1986;107-114.
32. Uyama O., Okamura N., Yanase M., Narita M., Kawabata K., Sugita M. Quantitative evaluation of vascular permeability in the gerbil brain after transient ischemia using Evans blue fluorescence. J. Cereb. Blood Flow. Metab. 8:1988;282-284.
33. Westergaard E., Go K.G., Klatzo I., Spatz M. Increased permeability of cerebral vessels to horseradish peroxidase induced by ischemia in Mongolian gerbils. Acta Neuropathol. 35:1976;307-325.
34. Wolman M., Klatzo I., Chui E., Wilmes F., Nishimoto K., Fujiwara K., Spatz M. Evaluation of the dye-protein tracers in pathophysiology of the blood-brain barrier. Acta Neuropathol. 54:1981;55-61.
35. Yang G.-Y., Betz A.L. Reperfusion-induced injury to the blood-brain barrier after middle cerebral artery occlusion in rats. Stroke. 25:1994;1658-1665.
36. Zea Longa E.L., Weinstein P.R., Carlson S., Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20:1989;84-91.